Skip to main content
SpringerLink
Log in

Foam Sclerotherapy

  • Chapter
  • First Online:
Practical Approach to the Management and Treatment of Venous Disorders

  • 1551 Accesses

Abstract

Over the past decade there has been an evolution from ultrasound-guided liquid sclerotherapy [1] to ultrasound guided foam sclerotherapy [2, 3]. Liquid sclerotherapy is used extensively to ablate small and medium sized tributary varicies usually with visual guidance. US guided liquid sclerosants have been shown to be able to close truncal veins but their success rates, whether injected by needle or catheter were inferior to that now achieved with EVTA. Ultrasound-guided foam sclerotherapy (UGFS), increasingly being referred to as endovenous chemical ablation, may be defined as the injection into a vein of a sclerosing agent which has been rendered foam in order to permanently ablate the target vein [4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Knight RM, Vin F, Zygmunt J. Ultrasonic guidance of injections into the superficial venous system. In: Davy A, Stemmer R, editors. Phlebologie’89. Montrouge: John Libbey Eurotext; 1989. p. 339–41.

    Google Scholar 

  2. Goldman MP, Bergan JJ, Guex JJ, Partsch H, Ramelet AA. Sclerotherapy: treatment of varicose and telangiectatic leg veins. 4th ed. Philadelphia: Mosby/Elsevier; 2007.

    Google Scholar 

  3. Cabrera J, Cabrera Jr J, Garcia-Olmedo MA. Treatment of varicose long saphenous veins with sclerosant in microfoam form: long term outcomes. Phlebology. 2000;15:19–23.

    Article  Google Scholar 

  4. Morrison N. Update on truncal vein management foam sclerotherapy. In: Greenhalgh R, editor. Charing cross vascular and endovascular controversies update. London: BIBA Medical Ltd; 2009.

    Google Scholar 

  5. Bergan JJ. The vein book. Burlington: Elsevier/Academic; 2007.

    Google Scholar 

  6. Mako S, Allaert F. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous veins: initial results. Dermatol Surg. 2003;29:1170–5.

    Article  PubMed  Google Scholar 

  7. Tessari L. Nouvelle technique d’obtention de la sclero-mousse. Phlebologie. 2000;53:129.

    Google Scholar 

  8. Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg. 2001;27:58–60.

    Article  PubMed  CAS  Google Scholar 

  9. Redondo P, Cabrera J. Microfoam sclerotherapy. Semin Cutan Med Surg. 2005;24:175–83.

    Article  PubMed  CAS  Google Scholar 

  10. Wright D, Gobin JP, Bradbury AW. VarisolveR polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial. Phlebology. 2006;21:180–90.

    Article  Google Scholar 

  11. Hsu T-S, Weiss R. Foam sclerotherapy: a new era. Arch Dermatol. 2003;139:1495–6.

    Google Scholar 

  12. Hamel-Desnos C, Desnos P, Wollmann JC, Ouvry P, Mako S, Allaert FA. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg. 2003;19:1170–5.

    Article  Google Scholar 

  13. Breu FX, Guggenbichler S. European consensus meeting on foam sclerotherapy, April 4–6, 2003, Tegernsee, Germany. Dermatol Surg. 2004;30:709–17.

    Article  PubMed  Google Scholar 

  14. Breu FX, Guggenbichler S, Wollmann JC. 2nd European consensus meeting on foam sclerotherapy. Tegernsee, Germany VASA. Eur J Vasc Med. 2008;37 Suppl 71:1–29.

    CAS  Google Scholar 

  15. Yamaki T, Nozaki M, Iwasaka S. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg. 2004;30:718–22.

    Article  PubMed  Google Scholar 

  16. Coleridge Smith P. Saphenous ablation: sclerosant or sclerofoam? Semin Vasc Surg. 2005;18:19–24.

    Article  PubMed  Google Scholar 

  17. Bountouroglou DG, Azzam M, Kakkos SK, Pathmarajah M, Young P, Geroulakos G. Ultrasound-guided foam sclerotherapy combined with sapheno-femoral ligation compared to surgical treatment of varicose veins: early results of a randomized controlled trial. Eur J Vasc Endovasc Surg. 2006;31:93–100.

    Article  PubMed  CAS  Google Scholar 

  18. Alos J, Carreno P, Lopez JA, Estadella B, Serra-Prat M, Marinel-Lo J. Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg. 2006;31:101–7.

    Article  PubMed  CAS  Google Scholar 

  19. Myers KA, Jolley D, Clough A, Kirwan J. Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance. Eur J Vasc Endovasc Surg. 2007;33:116–21.

    Article  PubMed  CAS  Google Scholar 

  20. Cabrera J, Cabrera Jr J, Garcia-Olmedo MA. Sclerosants in microfoam. A new approach in angiology. Int Angiol. 2001;20:322–9.

    PubMed  CAS  Google Scholar 

  21. Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectasias: history and analysis of safety and complications. Dermatol Surg. 2002;28:11–5.

    Article  PubMed  Google Scholar 

  22. Belcaro G, Cesarone MR, Di Renzo A. Foam-sclerotherapy, surgery, sclerotherapy, and combined treatment for varicose veins: a 10-year, prospective, randomized, controlled trial (VEDIGO trial). Angiology. 2003;54:307–15.

    Article  PubMed  CAS  Google Scholar 

  23. Barrett JM, Allen B, Ockelford A, Goldman MP. Microfoam ultrasound-guided sclerotherapy of varicose veins in 100 legs. Dermatol Surg. 2004;30:6–12.

    Article  PubMed  Google Scholar 

  24. Kern P, Ramelet AA, Wutschert R, Bounameaux H, Hayoz D. Single-blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins. Dermatol Surg. 2004;30:367–72.

    Article  PubMed  Google Scholar 

  25. Cabrera J, Redondo P, Becerra A. Ultrasound guided injection of polidocanol microfoam in the management of venous leg ulcers. Arch Dermatol. 2004;140:663–73.

    Article  Google Scholar 

  26. Barrett JM, Allen B, Ockelford A, Goldman MP. Microfoam ultrasound-guided sclerotherapy treatment for varicose veins in a subgroup with diameters at the junction of 10 mm or greater compared with a subgroup of less than 10 mm. Dermatol Surg. 2004;30:1386–90.

    Article  PubMed  Google Scholar 

  27. Pascarella L, Bergan JJ, Mekenas LV. Severe chronic venous insufficiency treated by foamed sclerosant. Ann Vasc Surg. 2006;20:83–91.

    Article  PubMed  Google Scholar 

  28. Bergan J, Pascarella L, Mekenas L. Venous disorders: treatment with sclerosant foam. J Cardiovasc Surg (Torino). 2006;47:9–18.

    CAS  Google Scholar 

  29. Darke SG, Baker SJ. Ultrasound-guided foam sclerotherapy for the treatment of varicose veins. Br J Surg. 2006;93:969–74.

    Article  PubMed  CAS  Google Scholar 

  30. Smith PC. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovasc Surg. 2006;32:577–83.

    Article  PubMed  Google Scholar 

  31. Perrin M, Gillet JL. Recidive de Varices A L’Aine Et A La Fosse Poplitee Apres Traitement Chirurgical. J Mal Vasc. 2006;31:236–46.

    Article  PubMed  CAS  Google Scholar 

  32. Perrin M, Gillet JL. Recidive de Varices A L’Aine Et A La Fosse Poplitee Apres Traitement Chirurgical. J Mal Vasc. 2006;31:236–46.

    Article  PubMed  CAS  Google Scholar 

  33. Cabrera J, Cabrera Jr J, Garcia-Olmedo MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol. 2003;139:1409–16.

    Article  PubMed  Google Scholar 

  34. Yamaki T, Nozaki M, Sasaki K. Color Duplex-guided sclerotherapy for the treatment of venous malformation. Dermatol Surg. 2000;26:323–8.

    Article  PubMed  CAS  Google Scholar 

  35. Ricci S, Georgiev M, Jawien A, Zamboni P. Scitatic nerve varices. Eur J Vasc Endovasc Surg. 2005;29:83–7.

    Article  PubMed  CAS  Google Scholar 

  36. Cabrera J, Cabrera Jr J. Nuevo metodo de esclerosis en las varices tronculares. Patologia Vasculares. 1995;4:55–73.

    Google Scholar 

  37. Eckmann DM, Kobayashi S, Li M. Microvascular embolization following polidocanol microfoam sclerosant administration. Dermatol Surg. 2005;31:636–43.

    Article  PubMed  CAS  Google Scholar 

  38. Wollman JC. The history of sclerosing foams. Dermatol Surg. 2004;30:694–703.

    Article  Google Scholar 

  39. Pascarella L, Bergan JJ, Yamada C, Mekenas L. Venous angiomata: treatment with sclerosant foam. Ann Vasc Surg. 2005;19:457–64.

    Article  PubMed  Google Scholar 

  40. Morrison N, Neuhardt DL, Rogers CR, McEown J, Morrison T, Johnson E, Salles-Cunha SX. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg. 2008;47:830–6.

    Article  PubMed  Google Scholar 

  41. Morrison N. Foam sclerotherapy: how to improve results and reduced side effects. Phlebologie. 2008;37:211–20.

    Google Scholar 

  42. Broderson JP, Geismar U. Catheter-assisted vein sclerotherapy: a new approach for sclerotherapy of the greater saphenous vein with a double-lumen balloon. Catheter Dermatol Surg. 2007;33:469–75.

    Google Scholar 

  43. Raines JK, Garcia de Quevedo W, Jahrmarkt S, Mackay E, Morrison N, Almeida J. Abbreviated method of determining vein volume in balloon-controlled vein ablation. Phlebology. 2007;22(1):40–4.

    Article  PubMed  CAS  Google Scholar 

  44. Hamel-Desnos C, Guias B, Jousse S, Desnos P, Bressollette L. Foam echosclerotherapy by puncture-direct injection: technique and quantities. J Mal Vasc. 2006;31:180–9.

    Article  PubMed  CAS  Google Scholar 

  45. Kakkos SK, Bountouroglou DG, Azzam M. Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: immediate results. J Endovasc Ther. 2006;13:357–64.

    Article  PubMed  Google Scholar 

  46. Guex JJ, Hamel-Desnos C, Gillet JL, Chleir R, Perrin M. Sclerotherapie des Varices par Mouse Echo-Guidee: Techniques de Mise an Oeuvre, Indications, Resultats Publies. Phlebologie. 2008;61:261–70.

    Google Scholar 

  47. Guex JJ, Allaert FA, Gillet JL, Chleir F. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg. 2005;31:123–8.

    Article  PubMed  CAS  Google Scholar 

  48. Coleridge Smith P. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovasc Surg. 2006;32:577–83.

    Article  PubMed  Google Scholar 

  49. O’Hare JL, Parkin D, Vandenbroeck CP, Earnshaw JJ. Mid term results of ultrasound guided foam sclerotherapy for complicated and uncomplicated varicose veins. Eur J Vasc Endovasc Surg. 2008;20:1–5.

    Google Scholar 

  50. Ceulen RP, Bullens-Goessens YI, de Venne SJ Pi-VAN, Nelemans PJ, Veraart JC, Sommer A. Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% polidocanol foam: results of a randomized controlled trial with 1-year follow-up. Dermatol Surg. 2007;33:276–81.

    Article  PubMed  CAS  Google Scholar 

  51. Abela R, Laimis A, Prionidis I, Mathai J, Gorton L, Browne T, Panayiotopoulos Y. Reverse foam sclerotherapy of the great saphenous vein with sapheno-femoral ligation compared to standard and invagination stripping: a prospective clinical series. Eur J Vasc Endovasc Surg. 2008;36:485–90.

    Article  PubMed  CAS  Google Scholar 

  52. Rao J, Wildemore JK, Goldman MP. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins. Dermatol Surg. 2005;31:631–5.

    Article  PubMed  CAS  Google Scholar 

  53. Rabe E, Otto J, Schliephake D, Pannier F. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial. Eur J Vasc Endovasc Surg. 2008;35:238–45.

    Article  PubMed  CAS  Google Scholar 

  54. Morrison N. The interaction and complimentary role of surgery, sclerotherapy and thermal ablation in the management of varicose veins – The US perspective. The Australian and New Zealand Society for Vascular Surgery, Melbourne; 2007.

    Google Scholar 

  55. McDonagh B, Huntley DE, Rosenfeld R, et al. Efficacy of the comprehensive objective mapping, precise image guided injection, anti-reflux ­positioning and sequential sclerotherapy (COMPASS) technique in the management of greater saphenous varicosities with saphenofemoral incompetence. Phlebology. 2002;17:19–28.

    Google Scholar 

  56. Grondin L. Foam echosclerotherapy of incompetent saphenous veins. Phlebolymphology. 2003;42:S24.

    Google Scholar 

  57. Rabe E, Pannier-Fischer F, Gerlach H, Breu FX, Guggenbichler S, Zabel M. Guidelines for sclerotherapy of varicose veins. Dermatol Surg. 2004;30:687–93.

    Article  PubMed  CAS  Google Scholar 

  58. Wollmann JC. An experimental model to pinpoint properties and behavior of sclerosing foams. 17th annual congress of the American College of Phlebology, San Diego; 2003.

    Google Scholar 

  59. Sierra A, Redondo P, Cabrera J, Cabrera J Jr, Garcia-Olmedo MA. Large volume microfoam therapy for recurrent varicose veins. 16th annual congress of the American College of Phlebology, Fort Lauderdale; 2002.

    Google Scholar 

  60. Morrison N. Large-volume, ultrasound-guided, polidocanol foam sclerotherapy: a prospective study of toxicity and complications. International vein congress 2004, Key Biscayne; 2004.

    Google Scholar 

  61. Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C. Systematic review of foam sclerotherapy for varicose veins. Br J Surg. 2007;94:925–36.

    Article  PubMed  CAS  Google Scholar 

  62. Gobin JP. French experience with sclerotherapy. Presented at Angiologia E Cirurgia Vascular, Uberlandia; 2008.

    Google Scholar 

  63. Fegan WG. Injection with compression as a treatment for varicose veins. Proc R Soc Med. 1965;58:874–6.

    PubMed  CAS  Google Scholar 

  64. Henriet JP. Expérience durant trois années de la mousse de polidocanol dans le traitement des varices réticulaires et des varicosities. Phlebologie. 1999;52:277–82.

    Google Scholar 

  65. O’Hare JL, Earnshaw JJ. The use of foam sclerotherapy for varicose veins: a survey of the members of the Vascular Society of Great Britain and Ireland. Eur J Vas Endovasc Surg. 2007;34:232–5.

    Article  Google Scholar 

  66. Hoffman K. An unusual complication of facial sclerotherapy. Dermatol Surg. 2003;29:423–4.

    Article  PubMed  Google Scholar 

  67. Benigni JP, Ratinahirana H, Bousser MG. Polidocanol 400 foam injection and migraine with visual aura [abstract]. 16th annual congress of the American College of Phlebology, Ft Lauderdale; 2002.

    Google Scholar 

  68. Scurr J, Gilling-Smith G, Fisher R. Letter to the editor re: systematic review of foam sclerotherapy for varicose veins. Br J Surg. 2007;94(925–936):1306–9.

    Google Scholar 

  69. Morrison N, Cavezzi A, Bergan J, Partsch H. Letter to the editor regarding ‘Stroke after varicose vein foam injection sclerotherapy’. J Vasc Surg. 2007;44:224–5.

    Article  Google Scholar 

  70. Harzheim M, Becher H, Klockgether T. Brain infarct from a paradoxical embolism following a varices operation. Dtsch Med Wochenschr. 2000;125:794–6.

    Article  PubMed  CAS  Google Scholar 

  71. Marrocco-Trischitta MM, Guerrini P, Abeni P, Stillo F. Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation. Dermatol Surg. 2002;28:153–5.

    Article  PubMed  Google Scholar 

  72. Ceulen R. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med. 1978;35:8–14.

    Google Scholar 

  73. Scurr JRH, Fisher RK, Wallace SB, Gilling-Smith GL. Anaphylaxis following foam sclerotherapy: a life threatening complication of non invasive treatment for varicose veins. Eur J Vasc Endovasc Surg. 2007;34:249.

    Article  Google Scholar 

  74. Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg. 2006;43:162–4.

    Article  PubMed  Google Scholar 

  75. Bush RG, Derrick M, Manjoney D. Major neurological events following foam sclerotherapy. Phlebology. 2008;23:189–92.

    Article  PubMed  CAS  Google Scholar 

  76. Morrison N, Neuhardt DL, Hansen K, Salles-Cunha SX. Tracking foam to the heart and brain following ultrasound-guided sclerotherapy of the lower extremities. Austral NZ J Phlebol. 2007;10(1):6–10.

    Google Scholar 

  77. Varcoe PF. Ultrasound guided sclerotherapy: efficacy, adverse effects and dosing. An international survey. Anz J Phleb. 2004;7:17–24.

    Google Scholar 

  78. Myers K, Jolley D. Factors affecting the risk of deep venous occlusion after ultrasound-guided sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg. 2008;20:1–4.

    Google Scholar 

  79. Anzola GP, Morandi E, Casilli F, Onorato E. Different degrees of right-to-left shunting predict migraine and stroke: data from 420 patients. Neurology. 2006;66:765–7.

    Article  PubMed  Google Scholar 

  80. Hanisch F, Müller T, Krivokuca M, Winterholler W. Stroke following variceal sclerotherapy. Eur J Med Res. 2004;9:282–4.

    PubMed  Google Scholar 

  81. Kolbeln T, Hinchliffe R, Lindbladn B. Catheter-directed foam sclerotherapy of axial saphenous reflux: early results. Phlebology. 2007;22:219–22.

    Article  Google Scholar 

  82. Neuhardt D. Incidence of deep vein thrombosis in a duplicated femoral vein following foam USG of the GSV. First days of phlebology, Parma; 2006.

    Google Scholar 

  83. Lai SW, Goldman MP. Does the relative silicone content of different syringes affect the stability of foam in sclerotherapy? J Drugs Dermatol. 2008;7:399–40.

    PubMed  Google Scholar 

  84. Wollmann JC. An experimental model to pinpoint properties and behavior of sclerosing foams. 17th annual congress of the American College of Phlebology, San Diego; 2003.

    Google Scholar 

  85. Tessari L. 8th international phlebological symposium, Bologna; 2006.

    Google Scholar 

  86. Morrison N, et al. Incidence of Side Effects Using Carbon Dioxide-Oxygen Foam for Chemical Ablation of Superficial Veins of the Lower Extremity. Eur J Vasc Endovasc Surg. 2010;40:407–413.

    Google Scholar 

  87. Morrison N. Studies on safety of foam sclerotherapy. In: Bergan JJ, Chang V, editors. Foam sclerotherapy: a textbook. London: Royal Society of Medicine Press Ltd; 2008.

    Google Scholar 

  88. Gibson K. Proprietary polidocanol endovenous microfoam (PEM) bubble embolization does not cause cerebral injury. Presented American College of Phlebology annual congress, Florida; 2008.

    Google Scholar 

Download references

Acknowledgements

The author gratefully acknowledges the contribution of Diana Neuhardt, RVT, of Compudiagnostics for her investigational help and provision of the excellent duplex images in this manuscript.

Author information

Authors and Affiliations

  1. Morrison Vein Institute, Scottsdale, AZ, USA

    Nick Morrison M.D.

Authors
  1. Nick Morrison M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nick Morrison M.D. .

Editor information

Editors and Affiliations

  1. PARK AVENUE 911, NEW YORK, 10021, New York, USA

    Neil S. Sadick

  2. College of Physicians and Surgeons, Radiology, Columbia University, New York, 10032, New York, USA

    Neil Khilnani

  3. Morrison Vein Institute, Tempe, 85282, Arizona, USA

    Nick Morrison

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Morrison, N. (2013). Foam Sclerotherapy. In: Sadick, N., Khilnani, N., Morrison, N. (eds) Practical Approach to the Management and Treatment of Venous Disorders. Springer, London. https://doi.org/10.1007/978-1-4471-2891-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2891-5_9

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2890-8

  • Online ISBN: 978-1-4471-2891-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation